Citric Acid Controls the Activity of YopH Bacterial Tyrosine Phosphatase

References

• Hawkins SG. ”Antimicrobial Activity of Cinnamic Acid, Citric Acid, Cinnamaldehyde, and Levulinic Acid Against Foodborne Pathogens”. Chancellor’s Honors Program Projects; 2014.
   Google Scholar
• Ryan EM, Duryee MJ, Hollins A, et al. Antioxidant properties of citric acid interfere with the uricase-based measurement of circulating uric acid. J Pharmac Biomed Anal. 2019;164:460–466. doi:10.1016/j.jpba.2018.11.011
   PubMed Web of Science ®Google Scholar
• Ciriminna R, Meneguzzo F, Delisi R, Pagliaro M. Citric acid: emerging applications of key biotechnology industrial product. Chem Cent J. 2017;11:22. doi:10.1186/s13065-017-0251-y
   PubMed Web of Science ®Google Scholar
• Koromyslova AD, White PA, Hansman GS. Treatment of norovirus particles with citrate. Virology. 2015;485:199–204. doi:10.1016/j.virol.2015.07.009
   PubMed Web of Science ®Google Scholar
• Eliuz EAE. Antimicrobial activity of citric acid against Escherichia coli, Staphylococcus aureus and Candida albicans as a sanitizer agent. J Fore Sci. 2020;8:295–301.
   Google Scholar
• Bielecki J. Emerging food pathogens and bacterial toxins. Acta Microbiol Pol. 2003;52:17–22.
   PubMedGoogle Scholar
• Wu HJ, Wang AH, Jennings MP. Discovery of virulence factors of pathogenic bacteria. Curr Opin Chem Biol. 2008;12(1):93–101. doi:10.1016/j.cbpa.2008.01.023
   PubMed Web of Science ®Google Scholar
• Black DS, Bliska JB. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J. 1997;16(10):2730–2744. doi:10.1093/emboj/16.10.2730
   PubMed Web of Science ®Google Scholar
• Persson C, Carballeira N, Wolf-Watz H, Fällman M. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J. 1997;16(9):2307–2318. doi:10.1093/emboj/16.9.2307
   PubMed Web of Science ®Google Scholar
• Andersson K, Carballeira N, Magnusson KE, et al. YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Mol Microbiol. 1996;20(5):1057–1069. doi:10.1111/j.1365-2958.1996.tb02546.x
   PubMed Web of Science ®Google Scholar
• Ernst JD. Bacterial inhibition of phagocytosis. Cell Microbiol. 2000;2(5):379–386. doi:10.1046/j.1462-5822.2000.00075.x
   PubMed Web of Science ®Google Scholar
• Aepfelbacher M, Zumbihl R, Ruckdeschel K, Jacobi CA, Barz C, Heesemann J. The tranquilizing injection of Yersinia proteins: a pathogen’s strategy to resist host defense. Biol Chem. 1999;380(7–8):795–802. doi:10.1515/BC.1999.099
   PubMed Web of Science ®Google Scholar
• Green SP, Hartland EL, Robins-Browne RM, Phillips WA. Role of YopH in the suppression of tyrosine phosphorylation and respiratory burst activity in murine macrophages infected with Yersinia enterocolitica. J Leukoc Biol. 1995;57(6):972–977. doi:10.1002/jlb.57.6.972
   PubMed Web of Science ®Google Scholar
• Yao T, Mecsas J, Healy JI, Falkow S, Chien Y. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med. 1999;190(9):1343–1350. doi:10.1084/jem.190.9.1343
   PubMed Web of Science ®Google Scholar
• de la Puerta ML, Trinidad AG, Del Carmen Rodríguez M, et al. Characterization of new substrates targeted by Yersinia tyrosine phosphatase YopH. PLoS One. 2009;4(2):e4431. doi:10.1371/journal.pone.0004431
   PubMed Web of Science ®Google Scholar
• Kuban-Jankowska A, Sahu KK, Niedzialkowski P, et al. Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: virulence factor of Yersinia pestis. Oncotarget. 2015;6(21):18364–18373. doi:10.18632/oncotarget.4625
   PubMedGoogle Scholar
• Kuban-Jankowska A, Kostrzewa T, Gorska-Ponikowska M. bacterial protein tyrosine phosphatases as possible targets for antimicrobial therapies in response to antibiotic resistance. Antioxidants. 2022;11(12):2397. doi:10.3390/antiox11122397
   Web of Science ®Google Scholar
• Kim SE, Bahta M, Lountos GT, Ulrich RG, Burke TR, Waugh DS. Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH. Acta Crystallogr D Biol Crystallogr. 2011;67(Pt 7):639–645. doi:10.1107/S0907444911018610
   PubMedGoogle Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Guan KL, Dixon JE. Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science. 1990;249(4968):553–556. doi:10.1126/science.2166336
   PubMed Web of Science ®Google Scholar
• Bliska JB, Guan KL, Dixon JE, Falkow S. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci U S A. 1991;88(4):1187–1191. doi:10.1073/pnas.88.4.1187
   PubMed Web of Science ®Google Scholar
• Stuckey JA, Schubert HL, Fauman EB, Zhang ZY, Dixon JE, Saper MA. Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate. Nature. 1994;370(6490):571–575. doi:10.1038/370571a0
   PubMed Web of Science ®Google Scholar
• Montagna LG, Ivanov MI, Bliska JB. Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition. J Biol Chem. 2001;276(7):5005–5011. doi:10.1074/jbc.M009045200
   PubMed Web of Science ®Google Scholar
• Evdokimov AG, Tropea JE, Routzahn KM, Copeland TD, Waugh DS. Structure of the N-terminal domain of Yersinia pestis YopH at 2.0 A resolution. Acta Crystallogr D Biol Crystallogr. 2001;57(Pt 6):793–799. doi:10.1107/s0907444901004875
   PubMedGoogle Scholar
• Hamid N, Gustavsson A, Andersson K, et al. YopH dephosphorylates cas and fyn-binding protein in macrophages. Microb Pathog. 1999;27(4):231–242. doi:10.1006/mpat.1999.0301
   PubMed Web of Science ®Google Scholar
• Black DS, Marie-Cardine A, Schraven B, Bliska JB. The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cell Microbiol. 2000;2(5):401–414. doi:10.1046/j.1462-5822.2000.00061.x
   PubMed Web of Science ®Google Scholar
• Alonso A, Bottini N, Bruckner S, et al. Lck dephosphorylation at Tyr-394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH. J Biol Chem. 2004;279(6):4922–4928. doi:10.1074/jbc.M308978200
   PubMed Web of Science ®Google Scholar
• Gerke C, Falkow S, Chien YH. The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. J Exp Med. 2005;201(3):361–371. doi:10.1084/jem.20041120
   PubMed Web of Science ®Google Scholar
• Stratford M, Anslow PA. Evidence that sorbic acid does not inhibit yeast as a classic ‘weak acid preservative’. Lett Appl Microbiol. 1998;27(4):203–206. doi:10.1046/j.1472-765x.1998.00424.x
   PubMed Web of Science ®Google Scholar
• Bjarnsholt T, Alhede M, Pø J, et al. Antibiofilm properties of acetic acid. Adv Wound Care. 2015;4(7):363–372. doi:10.1089/wound.2014.0554
   PubMed Web of Science ®Google Scholar
• Brul S, Coote P. Preservative agents in foods. Mode of action and microbial resistance mechanisms. Int J Food Microbiol. 1999;50(1–2):1–17. doi:10.1016/s0168-1605(99)00072-0
   PubMed Web of Science ®Google Scholar
• Souza JGS, Cordeiro JM, Lima CV, Barão VAR. Citric acid reduces oral biofilm and influences the electrochemical behavior of titanium: an in situ and in vitro study. J Periodontol. 2019;90(2):149–158. doi:10.1002/JPER.18-0178
   PubMed Web of Science ®Google Scholar
• Kundukad B, Udayakumar G, Grela E, et al. Weak acids as an alternative anti-microbial therapy. Biofilm. 2020;2:100019. doi:10.1016/j.bioflm.2020.100019
   PubMedGoogle Scholar
• Nural Y, Gemili M, Ulger M, Sari H, De Coen LM, Sahin E. Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives. Bioorg Med Chem Lett. 2018;28(5):942–946. doi:10.1016/j.bmcl.2018.01.045
   PubMed Web of Science ®Google Scholar